References
- ZimmermanHJHepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the LiverPhiladelphiaLippincott Williams & Wilkins1999
- KaplowitzNDrug-induced liver disordersDrug Safety200124748349011444721
- SpencerCMFauldsDEsomeprazoleDrugs2000602321329 discussion 330–110983736
- DaviesMWiltonLVShakirSASafety profile of esomeprazoleDrug Safety200831431332318366242
- MajithiaRJohnsonDAAre proton pump inhibitors safe during pregnancy and lactation?Drugs201272217117922239714
- The U.S. Food and Drug Administration [homepage on the Internet]Nexium (Esomeprazole Magnesium)2015 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm431648.htmAccessed September 28, 2015
- FontanaRJHayashiPHGuJIdiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onsetGastroenterology2014147196.e108.e24681128
- LeeWMDrug-induced hepatotoxicityN Engl J Med2003349547448512890847
- CapitainOLortholaryAAbadie-LacourtoisieSCytolytic hepatitis and esomeprazole during chemotherapyPresse Med200534171235123616230965
- KourySStoneCLa ChariteDOmeprazole and the development of acute hepatitisEur J Emerg Med1998544674709919455
- SuganoKKinoshitaYMiwaHTakeuchiTEsomeprazole NSAID Preventive Study GroupSafety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugsBMC Gastroenterol2013135423530709
- AnderssonTHassan-AlinMHasselgrenGRöhssKWeidolfLPharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazoleClin Pharmacokinet200140641142611475467
- Romero-GomezMOteroMSuarez-GarciaEDiazEGFobeloMCastro-FernandezMAcute hepatitis related to omeprazoleAm J Gastroenterol19999441119112010201510